Abbott recognized the importance of MR Conditional devices, so we designed accordingly.
Patients over 65 are at greater risk for stroke, dementia and musculoskeletal disorders.1
- Physicians prefer MR Conditional pacemakers when diagnosing many conditions, including those affecting the brain and spine2
- The Endurity MRI™ pacemaker allows for whole-body MRI scans depending on the MRI Ready lead(s) selected*
- The Endurity MRI pacemaker enables 1.5T or 3.0T MRI scans when used with Abbott MRI Ready leads
- The St. Jude Medical MRI Activator™ handheld device is an optional, easy-to-use device that can be used to program the pacemaker to pre-approval MRI settings pre- and post-MRI scan, decreasing the number of workflow steps and increasing clinical efficiency
MINIMIZE RISK OF HEART FAILURE HOSPITALIZATION
Unnecessary right ventricular (RV) pacing can exacerbate heart conditions.
- Pacing > 40% can lead to increased HF hospitalizations and mortality3
- Patients with low RV pacing (0-9%) have same negative outcomes as those with high RV pacing (40-49%)4
Abbott can help. We use a Ventricular Intrinsic Preference (VIP™) algorithm with dynamic AV delay, which are clinically proven to reduce unnecessary RV pacing. The VIP algorithm is shown to reduce heart-failure related hospitalization,5 and we offer RV pacing at desirable levels (10-19%).4
BUILDING COMPREHENSIVE CARDIAC ARRHYTHMIA MANAGEMENT
The Endurity MRI™ pacemaker is part of our arrhythmia management portfolio. Our vision is to transform the treatment of cardiac arrhythmias by designing cost-effective technologies that improve outcomes. Read more about our approach to cardiac arrhythmia management.
1. Levy, S. THE MOST COMMON ISSUES OF AGING. www.agingcare.com/Articles/common-issues-of-aging-102224.html
2. Jauch, E. C., Saver, J. L., Adams, H. P. Jr., Bruno, A., Connors, J. J., Demaerschalk, B. M., … Yonas, H. (2013). Guidelines for the early management of patients with acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 44(3), 870-947. http://dx.doi.org/10.1161/STR.0b013e318284056a
3. Wilkoff, B. L., Cook, J. R., Epstein, A. E., Greene, H. L., Hallstrom, A. P., Hsia, H., … Sharma, A., & DAVID Investigators. (2002). Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA, 288(24), 3115-3123. http://www.ncbi.nlm.nih.gov/pubmed/12495391
4. Olshansky, B., Day, J., Lerew, D., Brown, S., Stolen, K. Q., & INTRINSIC RV Investigators. Eliminating right ventricular pacing may not be best for patients requiring implantable cardioverter-defibrillators. Heart Rhythm, (7), 886-891. http://www.ncbi.nlm.nih.gov/pubmed/17599672
5. Faulknier, B., & Richards, M. (2012, December). The association of the use of the Ventricular Intrinsic Preference (VIP™) feature with heart failure hospitalization in pacemaker patients. Presented at the International Symposium on Progress in Clinical Pacing, Rome, Italy.